Pathogenesis of Abeta oligomers in synaptic failure

Related Experiment Video

Updated: May 18, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

Senthilkumar Sivanesan1, Aaron Tan, Jayakumar Rajadas

  • 1Aging and Neural Repair Group, Clinic of Neurology, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany.

Current Alzheimer Research
|October 6, 2012
PubMed

Insights

Soluble amyloid-beta (Abeta) oligomers in the brain damage synapses and impair memory in Alzheimer's disease (AD). These oligomers interact with receptors, leading to neuronal loss and memory failure.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Soluble amyloid-beta (Abeta) oligomers are linked to synaptic dysfunction and memory loss in Alzheimer's disease (AD).
  • Recent research highlights the role of Abeta dimers and trimers in AD pathology.
  • Abeta oligomers can bind to cellular prion protein, forming pores that disrupt membrane integrity.

Purpose of the Study:

  • To elucidate the mechanisms connecting Abeta oligomers to synapse damage and memory failure in AD.
  • To detail the receptor-mediated pathways involved in Abeta oligomer-induced neurotoxicity.
  • To review the impact of Abeta oligomers on synaptic proteins and neuronal function.

Main Methods:

  • Review of existing literature on Abeta oligomer interactions with neuronal receptors.
  • Analysis of signaling pathways involving NMDA, AMPA, nAChRs, p75NTR, and mGluR5.
  • Examination of downstream effects on calcium homeostasis, mitochondrial function, and synaptic protein levels.

Main Results:

  • Abeta oligomers activate multiple receptors, including NMDA and AMPA, leading to calcium influx.
  • This activation results in mitochondrial dysfunction, decreased CaMKII levels, and loss of synaptic proteins (PSD-95, dynamin-1, synaptophysin).
  • Altered neuronal membrane integrity, spine morphology, and P/Q calcium currents contribute to neuronal loss and memory deficits.

Conclusions:

  • Abeta oligomer-receptor interactions initiate a cascade of events leading to synapse damage.
  • These interactions disrupt synaptic function, ultimately causing memory failure in Alzheimer's disease.
  • Understanding these pathways is crucial for developing targeted AD therapies.

More Related Videos

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...